LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 45

Search options

  1. Article ; Online: Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection.

    Onabajo, Olusegun O / Mattapallil, Joseph J

    Frontiers in immunology

    2021  Volume 12, Page(s) 657679

    Abstract: Human Immunodeficiency Virus (HIV) and Simian Immunodeficiency Virus (SIV) are associated with severe perturbations in the gut mucosal environment characterized by massive viral replication and depletion of CD4 T cells leading to dysbiosis, breakdown of ... ...

    Abstract Human Immunodeficiency Virus (HIV) and Simian Immunodeficiency Virus (SIV) are associated with severe perturbations in the gut mucosal environment characterized by massive viral replication and depletion of CD4 T cells leading to dysbiosis, breakdown of the epithelial barrier, microbial translocation, immune activation and disease progression. Multiple mechanisms play a role in maintaining homeostasis in the gut mucosa and protecting the integrity of the epithelial barrier. Among these are the secretory IgA (sIgA) that are produced daily in vast quantities throughout the mucosa and play a pivotal role in preventing commensal microbes from breaching the epithelial barrier. These microbe specific, high affinity IgA are produced by IgA+ plasma cells that are present within the Peyer's Patches, mesenteric lymph nodes and the isolated lymphoid follicles that are prevalent in the lamina propria of the gastrointestinal tract (GIT). Differentiation, maturation and class switching to IgA producing plasma cells requires help from T follicular helper (Tfh) cells that are present within these lymphoid tissues. HIV replication and CD4 T cell depletion is accompanied by severe dysregulation of Tfh cell responses that compromises the generation of mucosal IgA that in turn alters barrier integrity leading to commensal bacteria readily breaching the epithelial barrier and causing mucosal pathology. Here we review the effect of HIV infection on Tfh cells and mucosal IgA responses in the GIT and the consequences these have for gut dysbiosis and mucosal immunopathogenesis.
    MeSH term(s) Animals ; B-Lymphocyte Subsets/immunology ; B-Lymphocyte Subsets/metabolism ; Cell Communication/immunology ; Gastrointestinal Microbiome/immunology ; HIV/immunology ; HIV Infections/immunology ; HIV Infections/metabolism ; HIV Infections/virology ; Homeostasis/immunology ; Host-Pathogen Interactions/immunology ; Humans ; Immunity, Mucosal ; Immunoglobulin A/immunology ; Immunoglobulin A, Secretory/immunology ; Intestinal Mucosa/immunology ; Intestinal Mucosa/metabolism ; Intestinal Mucosa/microbiology ; Plasma Cells/immunology ; Plasma Cells/metabolism ; Signal Transduction ; Simian Immunodeficiency Virus/immunology ; T-Lymphocytes, Helper-Inducer/immunology ; T-Lymphocytes, Helper-Inducer/metabolism
    Chemical Substances Immunoglobulin A ; Immunoglobulin A, Secretory
    Language English
    Publishing date 2021-03-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.657679
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: GALT CD4

    Onabajo, Olusegun O / Lewis, Mark G / Mattapallil, Joseph J

    Cellular immunology

    2021  Volume 366, Page(s) 104396

    Abstract: Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are characterized by dramatic alterations in the mucosal CD4 T cell compartment. Though viremia is effectively suppressed, and peripheral CD4 T cell numbers recover to ... ...

    Abstract Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are characterized by dramatic alterations in the mucosal CD4 T cell compartment. Though viremia is effectively suppressed, and peripheral CD4 T cell numbers recover to near healthy levels after highly active anti-retroviral therapy (HAART), some of the dysfunctional consequences of HIV infection continue to persist during therapy. We hypothesized that CD4 T follicular helper (Tfh) cell deficiencies may play a role in this process. Using the macaque model we show that SIV infection was associated with a significant loss of Tfh cells in the GALT that drain the mesentery lining the gastrointestinal tract (GIT). Loss of Tfh cells significantly correlated with the depletion of the overall memory CD4 T cell compartment; most Tfh cells in the GALT expressed a CD95+CD28+ memory phenotype suggesting that infection of the memory compartment likely drives the loss of GALT Tfh cells during infection. Continuous anti-retroviral therapy (cART) was accompanied by a significant repopulation of Tfh cells in the GALT to levels similar to those of uninfected animals. Repopulating Tfh cells displayed significantly higher capacity to produce IL-21 as compared to SIV infected animals suggesting that cART fully restores Tfh cells that are functionally capable of supporting GC reactions in the GALT.
    MeSH term(s) Animals ; Antiretroviral Therapy, Highly Active/methods ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/immunology ; Cell Movement ; Disease Models, Animal ; Germinal Center/immunology ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV-1/physiology ; Humans ; Immunologic Memory ; Interleukins/metabolism ; Intestines/immunology ; Lymphoid Tissue/immunology ; Lymphopenia ; Macaca ; Programmed Cell Death 1 Receptor/metabolism ; Simian Acquired Immunodeficiency Syndrome/drug therapy ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Immunodeficiency Virus/physiology
    Chemical Substances Interleukins ; Programmed Cell Death 1 Receptor ; interleukin-21 (MKM3CA6LT1)
    Language English
    Publishing date 2021-06-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80094-6
    ISSN 1090-2163 ; 0008-8749
    ISSN (online) 1090-2163
    ISSN 0008-8749
    DOI 10.1016/j.cellimm.2021.104396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.

    Onabajo, Olusegun O / Muchmore, Brian / Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2019  Volume 39, Issue 10, Page(s) 636–641

    Abstract: Since its discovery in 2013, interferon lambda 4 (IFN-λ4) has received a reputation as a paradoxical type III IFN. Difficulties in detecting IFN-λ4, especially in secreted form even led to questions about its existence. However, the genetic ability to ... ...

    Abstract Since its discovery in 2013, interferon lambda 4 (IFN-λ4) has received a reputation as a paradoxical type III IFN. Difficulties in detecting IFN-λ4, especially in secreted form even led to questions about its existence. However, the genetic ability to generate IFN-λ4, determined by the presence of the rs368234815-ΔG allele, is the strongest predictor of impaired clearance of hepatitis C virus (HCV) infection in humans. Significant modulation of IFN-λ4 activity by a genetic variant (P70S) supports IFN-λ4, and not other type III IFNs encoded in the same genomic locus, as the primary functional cause of the association with HCV clearance. Although the ability to produce IFN-λ4 is associated with decreased HCV clearance, the recombinant IFN-λ4 is active against HCV and other viruses. These observations present an apparent conundrum-when and how does a presumably good IFN, with anti-HCV activity, interfere with the ability to clear HCV? In this review, we discuss findings that suggest potential mechanisms for explaining this conundrum.
    MeSH term(s) Hepacivirus/genetics ; Hepacivirus/metabolism ; Hepatitis C/genetics ; Hepatitis C/metabolism ; Hepatitis C/pathology ; Humans ; Interleukins/genetics ; Interleukins/metabolism ; Polymorphism, Genetic
    Chemical Substances IFNL4 protein, human ; Interleukins
    Language English
    Publishing date 2019-06-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2019.0044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19.

    Shivram, Haridha / Hackney, Jason A / Rosenberger, Carrie M / Teterina, Anastasia / Qamra, Aditi / Onabajo, Olusegun / McBride, Jacqueline / Cai, Fang / Bao, Min / Tsai, Larry / Regev, Aviv / Rosas, Ivan O / Bauer, Rebecca N

    iScience

    2023  Volume 26, Issue 9, Page(s) 107597

    Abstract: High interleukin (IL)-6 levels are associated with greater COVID-19 severity. IL-6 receptor blockade by tocilizumab (anti-IL6R; Actemra) is used globally for the treatment of severe COVID-19, yet a molecular understanding of the therapeutic benefit ... ...

    Abstract High interleukin (IL)-6 levels are associated with greater COVID-19 severity. IL-6 receptor blockade by tocilizumab (anti-IL6R; Actemra) is used globally for the treatment of severe COVID-19, yet a molecular understanding of the therapeutic benefit remains unclear. We characterized the immune profile and identified cellular and molecular pathways modified by tocilizumab in peripheral blood samples from patients enrolled in the COVACTA study, a phase 3, randomized, double-blind, placebo-controlled trial of the efficacy and safety of tocilizumab in hospitalized patients with severe COVID-19. We identified markers of inflammation, lymphopenia, myeloid dysregulation, and organ injury that predict disease severity and clinical outcomes. Proteomic analysis confirmed a pharmacodynamic effect for tocilizumab and identified novel pharmacodynamic biomarkers. Transcriptomic analysis revealed that tocilizumab treatment leads to faster resolution of lymphopenia and myeloid dysregulation associated with severe COVID-19, indicating greater anti-inflammatory activity relative to placebo and potentially leading to faster recovery in patients hospitalized with COVID-19.
    Language English
    Publishing date 2023-08-11
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.107597
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6

    Onabajo, Olusegun O / Lewis, Mark G / Mattapallil, Joseph J

    Journal of cellular and molecular medicine

    2018  Volume 22, Issue 11, Page(s) 5682–5687

    Abstract: Human immunodeficiency virus (HIV) infection is characterized by dysfunctional B cell responses. Here we show that chronic simian immunodeficiency virus (SIV) infection is characterized by an expansion of either lymph node germinal center (GC) B cells ... ...

    Abstract Human immunodeficiency virus (HIV) infection is characterized by dysfunctional B cell responses. Here we show that chronic simian immunodeficiency virus (SIV) infection is characterized by an expansion of either lymph node germinal center (GC) B cells that co-express Bcl6, Ki-67 and IL-21R and correlate with expanded T follicular helper (Tfh) cells or B cells that lack Bcl6, Ki-67 and IL-21R but express high levels of anti-apoptotic Bcl2 that negatively correlate with Tfh cells. The lack of Tfh cells likely contributes to persistence of dysfunctional non-proliferating B cells during chronic infection. These findings have implications for protective immunity in HIV-infected individuals who harbour low frequencies of Tfh cells.
    MeSH term(s) Animals ; B-Lymphocytes/immunology ; B-Lymphocytes/pathology ; Cell Differentiation/immunology ; Germinal Center/immunology ; Germinal Center/virology ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/pathology ; HIV Infections/virology ; Humans ; Lymph Nodes/immunology ; Lymph Nodes/pathology ; Macaca mulatta/immunology ; Phenotype ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-6/genetics ; Simian Acquired Immunodeficiency Syndrome/genetics ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Acquired Immunodeficiency Syndrome/pathology ; Simian Acquired Immunodeficiency Syndrome/virology ; Simian Immunodeficiency Virus/genetics ; Simian Immunodeficiency Virus/immunology ; Simian Immunodeficiency Virus/pathogenicity ; T-Lymphocytes, Helper-Inducer/immunology ; T-Lymphocytes, Helper-Inducer/pathology
    Chemical Substances Proto-Oncogene Proteins c-bcl-2 ; Proto-Oncogene Proteins c-bcl-6
    Language English
    Publishing date 2018-09-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2074559-X
    ISSN 1582-4934 ; 1582-4934 ; 1582-1838
    ISSN (online) 1582-4934
    ISSN 1582-4934 ; 1582-1838
    DOI 10.1111/jcmm.13844
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.

    Mattathil, Jeffy G / Volz, Asisa / Onabajo, Olusegun O / Maynard, Sean / Bixler, Sandra L / Shen, Xiaoying X / Vargas-Inchaustegui, Diego / Robert-Guroff, Marjorie / Lebranche, Celia / Tomaras, Georgia / Montefiori, David / Sutter, Gerd / Mattapallil, Joseph J

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 1264

    Abstract: Human immunodeficiency virus (HIV) is a mucosally transmitted virus that causes immunodeficiency and AIDS. Developing efficacious vaccines to prevent infection is essential to control the epidemic. Protecting the vaginal and rectal mucosa, the primary ... ...

    Abstract Human immunodeficiency virus (HIV) is a mucosally transmitted virus that causes immunodeficiency and AIDS. Developing efficacious vaccines to prevent infection is essential to control the epidemic. Protecting the vaginal and rectal mucosa, the primary routes of HIV entry has been a challenge given the significant compartmentalization between the mucosal and peripheral immune systems. We hypothesized that direct intranodal vaccination of mucosa associated lymphoid tissue (MALT) such as the readily accessible palatine tonsils could overcome this compartmentalization. Here we show that rhesus macaques primed with plasmid DNA encoding SIVmac251-env and gag genes followed by an intranodal tonsil MALT boost with MVA encoding the same genes protects from a repeated low dose intrarectal challenge with highly pathogenic SIVmac251; 43% (3/7) of vaccinated macaques remained uninfected after 9 challenges as compared to the unvaccinated control (0/6) animals. One vaccinated animal remained free of infection even after 22 challenges. Vaccination was associated with a ~2 log decrease in acute viremia that inversely correlated with anamnestic immune responses. Our results suggest that a combination of systemic and intranodal tonsil MALT vaccination could induce robust adaptive and innate immune responses leading to protection from mucosal infection with highly pathogenic HIV and rapidly control viral breakthroughs.
    MeSH term(s) Animals ; Humans ; Female ; Vaccinia ; Palatine Tonsil ; Macaca mulatta ; Vaccinia virus ; Vaccination ; Lymphoma, B-Cell, Marginal Zone ; HIV Infections
    Language English
    Publishing date 2023-03-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-36907-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Expansion or depletion of T follicular helper cells during HIV infection: consequences for B cell responses.

    Onabajo, Olusegun O / Mattapallil, Joseph J

    Current HIV research

    2014  Volume 11, Issue 8, Page(s) 595–600

    Abstract: HIV infection is characterized by aberrant B cell responses and B cell dysfunction. These dysfunctional responses have been extensively documented in peripheral blood and organized lymphoid tissues such as the lymph nodes. Though the loss of CD4 T cell ... ...

    Abstract HIV infection is characterized by aberrant B cell responses and B cell dysfunction. These dysfunctional responses have been extensively documented in peripheral blood and organized lymphoid tissues such as the lymph nodes. Though the loss of CD4 T cell help has been thought to play a key role in dysfunctional B cell responses, recent studies have implicated a subset of CD4 T helper cells called the T follicular helper (Tfh) cells in this process. Tfh cells interact with B cells and play a key role in mediating the germinal center reaction, and driving the differentiation and maturation of B cells. Why Tfh expands in some HIV infected individuals as compared to their loss in others is still not clear. Here we review some of the recent developments in the field and discuss the implications of Tfh cell dysregulation on B cell responses during HIV infection.
    MeSH term(s) B-Lymphocytes/physiology ; CD4-Positive T-Lymphocytes/physiology ; Cell Differentiation/physiology ; HIV Infections/immunology ; Humans ; Lymphocyte Depletion ; T-Lymphocytes, Helper-Inducer/physiology
    Language English
    Publishing date 2014-02-25
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2192348-6
    ISSN 1873-4251 ; 1570-162X
    ISSN (online) 1873-4251
    ISSN 1570-162X
    DOI 10.2174/1570162x12666140225153552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs.

    Paquin, Ashley / Onabajo, Olusegun O / Tang, Wei / Prokunina-Olsson, Ludmila

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

    2016  Volume 36, Issue 1, Page(s) 30–36

    Abstract: IFN-λ4 is a novel type-III interferon with strong clinical significance in humans. Only a subset of individuals--up to 10% of Asians, 50% of Europeans, and 90% of Africans--carry the ΔG allele of a genetic variant rs368234815-TT/ΔG and are genetically ... ...

    Abstract IFN-λ4 is a novel type-III interferon with strong clinical significance in humans. Only a subset of individuals--up to 10% of Asians, 50% of Europeans, and 90% of Africans--carry the ΔG allele of a genetic variant rs368234815-TT/ΔG and are genetically able to produce IFN-λ4 protein. Carriers of the ΔG allele have impaired ability to clear infection with hepatitis C virus (HCV). IFN-λ4 is also predicted to exist and be functionally important in several nonhuman mammals. In this study, we present the first comparative analysis of 12 mammalian IFN-λ4 orthologs in a human hepatic cell line, HepG2, which supports signaling of the human IFN-λ4. We show that despite differences in protein sequences, functional properties of the recombinant human and nonhuman IFN-λ4 proteins are comparable-they are all expressed as predominantly cytoplasmic proteins that are biologically active for induction of interferon signaling. We show that several IFN-λ4 orthologs can be detected by Western blotting, flow cytometry, and confocal imaging using a monoclonal antibody developed for the human IFN-λ4. Studies of IFN-λ4 in animals should help improve our understanding of the biology of this novel clinically important interferon in normal and disease conditions.
    MeSH term(s) Amino Acid Sequence ; Animals ; Cytosol/immunology ; Cytosol/metabolism ; Gene Expression ; Genes, Reporter ; Hep G2 Cells ; Humans ; Interleukins/genetics ; Interleukins/immunology ; Luciferases/genetics ; Luciferases/immunology ; Molecular Sequence Data ; Plasmids/chemistry ; Plasmids/metabolism ; Recombinant Proteins/genetics ; Recombinant Proteins/immunology ; Sequence Alignment ; Sequence Homology, Amino Acid ; Species Specificity ; Transfection
    Chemical Substances IFNL4 protein, human ; Interleukins ; Recombinant Proteins ; Luciferases (EC 1.13.12.-)
    Keywords covid19
    Language English
    Publishing date 2016-01
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 1226675-9
    ISSN 1557-7465 ; 1079-9907
    ISSN (online) 1557-7465
    ISSN 1079-9907
    DOI 10.1089/jir.2015.0096
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.

    Onabajo, Olusegun O / Wang, Fang / Lee, Mei-Hsuan / Florez-Vargas, Oscar / Obajemu, Adeola / Tanikawa, Chizu / Vargas, Joselin M / Liao, Shu-Fen / Song, Ci / Huang, Yu-Han / Shen, Chen-Yang / Banday, A Rouf / O'Brien, Thomas R / Hu, Zhibin / Matsuda, Koichi / Prokunina-Olsson, Ludmila

    Frontiers in immunology

    2021  Volume 12, Page(s) 692263

    Abstract: ... IFNL3/ ... ...

    Abstract IFNL3/IFNL4
    MeSH term(s) Adult ; Apoptosis ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/virology ; Case-Control Studies ; Cell Proliferation ; Databases, Factual ; Endoplasmic Reticulum Stress ; Female ; Genetic Predisposition to Disease ; Hep G2 Cells ; Hepatitis C/genetics ; Hepatitis C/metabolism ; Hepatitis C/virology ; Humans ; Interferons/genetics ; Interleukins/genetics ; Interleukins/metabolism ; Japan ; Liver/metabolism ; Liver/pathology ; Liver Cirrhosis/genetics ; Liver Cirrhosis/metabolism ; Liver Cirrhosis/prevention & control ; Liver Cirrhosis/virology ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Liver Neoplasms/virology ; Male ; Middle Aged ; Phenotype ; Polymorphism, Genetic ; Protective Factors ; Risk Assessment ; Risk Factors ; Taiwan
    Chemical Substances interferon-lambda, human ; IFNL4 protein, human ; Interleukins ; Interferons (9008-11-1)
    Language English
    Publishing date 2021-08-23
    Publishing country Switzerland
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't ; Video-Audio Media
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.692263
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Tocilizumab treatment leads to early resolution of myeloid dysfunction and lymphopenia in patients hospitalized with COVID-19

    Shivram, Haridha / Hackney, Jason A. / Rosenberger, Carrie M / Teterina, Anastasia / Qamra, Aditi / Onabajo, Olusegun / McBride, Jacqueline / Cai, Fang / Bao, Min / Tsai, Larry / Regev, Aviv / Rosas, Ivan O. / Bauer, Rebecca N.

    bioRxiv

    Abstract: Tocilizumab, an anti-interleukin-6 receptor inhibitor, is recommended in global treatment guidelines for patients hospitalized with severe COVID-19. Using proteomic and transcriptomic analysis, we characterized the immune profile and identified cellular ... ...

    Abstract Tocilizumab, an anti-interleukin-6 receptor inhibitor, is recommended in global treatment guidelines for patients hospitalized with severe COVID-19. Using proteomic and transcriptomic analysis, we characterized the immune profile and identified cellular and molecular pathways directly modified by tocilizumab in peripheral blood samples collected from patients enrolled in the COVACTA study, a phase 3, randomized, double-blind, placebo-controlled trial, to assess the efficacy and safety of tocilizumab in hospitalized patients with severe COVID-19 pneumonia. We identified factors predicting disease severity and clinical outcomes, including markers of inflammation, lymphopenia, myeloid dysfunction, and organ injury. Proteomic analysis confirmed a pharmacodynamic effect for tocilizumab. Transcriptomic analysis revealed that tocilizumab treatment leads to faster resolution of lymphopenia and myeloid dysfunction associated with severe COVID-19, thus defining an anti-inflammatory mechanism of action for the beneficial effects of tocilizumab in patients hospitalized with COVID-19.
    Keywords covid19
    Language English
    Publishing date 2022-10-28
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2022.10.27.514096
    Database COVID19

    Kategorien

To top